Is CRK Stock Worth Buying Despite Heavy Spending and Weak Estimates?

Comstock Resources, Inc. CRK offers a clear valuation-versus-risk tradeoff. Its deep Haynesville and Bossier inventory and recovering production support long-term optionality, but heavy spending, leverage and weaker earnings estimates limit the near-term case.

The stock’s discount on one valuation measure is not enough to resolve that tension. Investors still have to weigh improving operations against a capital program that remains larger than internally generated cash flow.

CRK's Valuation Is Mixed Rather Than Cheap

CRK trades at about 2.0X forward 12-month sales, below the Zacks sub-industry’s 3.7X but above its five-year median of 1.7X. Its forward price-to-earnings multiple of about 35.3X is also well above the industry comparison of 9.9X, weakening the argument that the shares are broadly inexpensive.

Natural-gas investors can also compare CRK with CNX Resources Corporation CNX, an Appalachian natural gas development, production and midstream company. EQT Corporation EQT is another relevant reference point as a vertically integrated natural gas producer with production and midstream operations focused in the Appalachian Basin.

Comstock's Capital Load Keeps Leverage High

Comstock ended the second quarter of 2026 with about $3.13 billion of total debt and $45 million of cash, while last-12-month net leverage was 3 times. First-half cash capital expenditures of $829.5 million exceeded $442.2 million of operating cash flow.

The Pinnacle transaction reduced fixed charges and left the midstream unit debt-free, but the upstream funding burden remains substantial. Comstock still expects 2026 total capital spending of $1.45-$1.55 billion, keeping financial flexibility closely tied to natural gas prices and operating cash generation.

CRK's Production Recovery Offers Some Support

Second-quarter production rebounded 16% sequentially and 1% year over year to 113.1 Bcfe. Unit production costs improved to 77 cents per Mcfe from 93 cents in the first quarter, helped by higher production and lower lifting, general and administrative, tax and gathering costs per unit.

Management guides third-quarter production to 1.3-1.4 Bcfe per day. The company also plans to turn 48 legacy and 21 Western Haynesville wells to sales in 2026, so continued execution across its drilling program is important to sustaining the recovery.

Comstock's Estimate Revisions Argue for Patience

The Zacks Consensus Estimate for 2026 earnings is 40 cents per share, down 19.5% over the past four weeks. The 2027 consensus estimate stands at 50 cents per share, leaving the earnings outlook dependent on better commodity pricing and continued operating progress.

Second-quarter revenues missed the consensus mark by 14.9%, even though adjusted earnings of 3 cents per share topped expectations. Comstock also pays no dividend, so shareholder returns remain more dependent on commodity prices, production growth and execution.

Image Source: Zacks Investment Research

CRK's Sell Signal Keeps the Value Case in Check

The bottom line is that CRK has asset depth and improving production, but its spending requirements, leverage and weaker estimate trend argue for patience. The current valuation discount on sales does not fully offset those risks, especially with earnings-based valuation still elevated.

CRK currently has a Zacks Rank #4 (Sell). You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.

It also has a Value Score of B, Growth Score of D, Momentum Score of F and VGM Score of D. The Value Score reflects some valuation appeal, but the weaker Growth and Momentum Scores and the Sell rank indicate that the stock does not currently combine favorable style characteristics with supportive estimate revisions.

Research Chief Names "Single Best Pick to Double"

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

This company targets millennial and Gen Z audiences, generating nearly $1 billion in revenue last quarter alone. A recent pullback makes now an ideal time to jump aboard. Of course, all our elite picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more than 9 months.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research